These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3658828)

  • 21. Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation.
    Stromberg J; Martinez A; Benson R; Garton G; Diokno A; Gonzalez J; Zincke H; Schray M; Edmundson G; Brabbins D
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):67-75. PubMed ID: 8270460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy.
    Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
    Cancer J; 2001; 7(5):404-12. PubMed ID: 11693899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer.
    Prestidge BR; Hoak DC; Grimm PD; Ragde H; Cavanagh W; Blasko JC
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):31-9. PubMed ID: 9054874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809.
    Hurwitz MD; Halabi S; Ou SS; McGinnis LS; Keuttel MR; Dibiase SJ; Small EJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):814-9. PubMed ID: 18407435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer.
    Pellizzon AC; Nadalin W; Salvajoli JV; Fogaroli RC; Novaes PE; Maia MA; Ferrigno R
    Radiother Oncol; 2003 Feb; 66(2):167-72. PubMed ID: 12648788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose-rate brachytherapy in the treatment of carcinoma of the prostate.
    Syed AM; Puthawala A; Sharma A; Gamie S; Londrc A; Cherlow JM; Damore SJ; Nazmy N; Sheikh KM; Ko SJ
    Cancer Control; 2001; 8(6):511-21. PubMed ID: 11807421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
    Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
    Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma.
    Ragde H; Elgamal AA; Snow PB; Brandt J; Bartolucci AA; Nadir BS; Korb LJ
    Cancer; 1998 Sep; 83(5):989-1001. PubMed ID: 9731904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose rate interstitial with external beam irradiation for localized prostate cancer--results of a prospective trial.
    Dinges S; Deger S; Koswig S; Boehmer D; Schnorr D; Wiegel T; Loening SA; Dietel M; Hinkelbein W; Budach V
    Radiother Oncol; 1998 Aug; 48(2):197-202. PubMed ID: 9783892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience.
    Jabbari S; Hsu IC; Kawakami J; Weinberg VK; Speight JL; Gottschalk AR; Roach M; Shinohara K
    Brachytherapy; 2009; 8(4):339-44. PubMed ID: 19428310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method.
    Kang SK; Chou RH; Dodge RK; Clough RW; Kang HL; Bowen MG; Steffey BA; Das SK; Zhou SM; Whitehurst AW; Buckley NJ; Kim JH; Joyner RE; Sarmina I; Montana GS; Ingram SS; Anscher MS
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):937-45. PubMed ID: 11429221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic significance of Gleason Grade in patients treated with permanent prostate brachytherapy.
    Potters L; Purrazzella R; Brustein S; Fearn P; Huang D; Leibel SA; Kattan MW
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):749-54. PubMed ID: 12788181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98-05).
    Lawton CA; DeSilvio M; Lee WR; Gomella L; Grignon D; Gillin M; Morton G; Pisansky T; Sandler H
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):39-47. PubMed ID: 17084551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of extraprostatic cancer in clinically organ-confined prostate cancer by permanent interstitial brachytherapy: is extraprostatic seed placement necessary?
    Davis BJ; Haddock MG; Wilson TM; Rothenberg HJ; Bostwick DG; Herman MG; Pisansky TM
    Tech Urol; 2000 Jun; 6(2):70-7. PubMed ID: 10798803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transurethral intracavitary irradiation for carcinoma of the prostate].
    Kigure T; Harada T; Nishizawa O; Miyagata S; Koh D; Shimoda J; Yoshida K; Satoh Y; Tsukada T; Tsuchida S
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):305-11. PubMed ID: 2041274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
    Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
    J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probability of late rectal morbidity in 125I prostate brachytherapy.
    Waterman FM; Dicker AP
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):342-53. PubMed ID: 12527047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostatic conformal brachytherapy: 125I/103Pd postoperative dosimetric analysis.
    Merrick GS; Butler WM; Dorsey AT; Walbert HL
    Radiat Oncol Investig; 1997; 5(6):305-13. PubMed ID: 9436248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First report of transperineal polyethylene glycol hydrogel spacer use to curtail rectal radiation dose after permanent iodine-125 prostate brachytherapy.
    Beydoun N; Bucci JA; Chin YS; Malouf D; Enari E; Painter SD
    Brachytherapy; 2013; 12(4):368-74. PubMed ID: 23453682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term results of treatment for prostate carcinoma by staging pelvic lymph node dissection and definitive irradiation using low-dose rate temporary iridium-192 interstitial implant and external beam radiotherapy.
    Puthawala AA; Syed AM; Austin PA; Cherlow JM; Perley JM; Shanberg AM; Sawyer DE; Ingram JE; Baghdassarian R; Wachs BH; Perley JE; Londrc A; Espinoza-Ferrel T
    Cancer; 2001 Oct; 92(8):2084-94. PubMed ID: 11596024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.